Compare RVTY & DOCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVTY | DOCU |
|---|---|---|
| Founded | 1937 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.6B |
| IPO Year | 1994 | 2018 |
| Metric | RVTY | DOCU |
|---|---|---|
| Price | $98.99 | $54.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 17 |
| Target Price | ★ $109.67 | $63.33 |
| AVG Volume (30 Days) | 1.6M | ★ 2.9M |
| Earning Date | 05-05-2026 | 06-04-2026 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.36 | ★ 1.48 |
| Revenue | ★ $3,311,822,000.00 | $3,219,500,000.00 |
| Revenue This Year | $6.37 | $10.58 |
| Revenue Next Year | $5.10 | $7.33 |
| P/E Ratio | $279.22 | ★ $38.53 |
| Revenue Growth | N/A | ★ 8.16 |
| 52 Week Low | $81.22 | $40.16 |
| 52 Week High | $118.30 | $94.67 |
| Indicator | RVTY | DOCU |
|---|---|---|
| Relative Strength Index (RSI) | 54.80 | 65.22 |
| Support Level | $94.04 | $42.35 |
| Resistance Level | $102.16 | $71.47 |
| Average True Range (ATR) | 3.25 | 2.21 |
| MACD | 0.29 | 0.78 |
| Stochastic Oscillator | 46.90 | 79.21 |
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.